Entry |
|
Name |
Flavoxate (INN); Bladuril (TN) |
Formula |
C24H25NO4
|
Exact mass |
391.1784
|
Mol weight |
391.46
|
Structure |

|
Simcomp |
|
Remark |
Product (DG00477): | D00718<JP/US> |
|
Efficacy |
Antipollakisuria, Phosphodiesterase inhibitor |
Target |
|
Pathway |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BD Drugs for urinary frequency and incontinence
G04BD02 Flavoxate
D07961 Flavoxate (INN)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Flavoxate
D07961 Flavoxate (INN)
Second-class OTC drugs
Inorganic and organic chemicals
Flavoxate
D07961 Flavoxate (INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE
D07961 Flavoxate (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 C8x C 23.5200 -17.0800
2 C8x C 23.5200 -18.4800
3 C8x C 24.7100 -19.1800
4 C8y C 25.9700 -18.4800
5 C8y C 25.9700 -17.0800
6 C8y C 24.7100 -16.3100
7 C8y C 27.1600 -19.1800
8 C8y C 28.4200 -18.4800
9 C8y C 28.4200 -17.0800
10 O2x O 27.1600 -16.3100
11 C8y C 29.6100 -16.3100
12 C8x C 30.8000 -17.0800
13 C8x C 31.9900 -16.3100
14 C8x C 31.9900 -14.9100
15 C8x C 30.8000 -14.2100
16 C8x C 29.6100 -14.9100
17 O5x O 27.1600 -20.5800
18 C1a C 29.6266 -19.1900
19 C7a C 24.6920 -14.9101
20 O7a O 23.4844 -14.2334
21 O6a O 25.9086 -14.1866
22 C1b C 22.2666 -14.9580
23 C1b C 21.0495 -14.2766
24 N1y N 19.8602 -14.9845
25 C1x C 18.6518 -14.3080
26 C1x C 17.4487 -15.0239
27 C1x C 17.4672 -16.4238
28 C1x C 18.6756 -17.1003
29 C1x C 19.8787 -16.3844
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 7 17 2
20 8 18 1
21 6 19 1
22 19 20 1
23 19 21 2
24 20 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 24 29 1
|